Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
176
Frequently Asked Questions
What is Market Cap of Arcturus Therapeutics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Arcturus Therapeutics Holdings Inc market cap is $492.31M.
What is the 52-week high for Arcturus Therapeutics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Arcturus Therapeutics Holdings Inc 52 week high is $25.88 as of September 16, 2025.
What is the 52-week low for Arcturus Therapeutics Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Arcturus Therapeutics Holdings Inc 52 week low is $8.04 as of September 16, 2025.
What is Arcturus Therapeutics Holdings Inc stock price today?
Arcturus Therapeutics Holdings Inc stock price today is $17.98.
What was Arcturus Therapeutics Holdings Inc stock price yesterday?
Arcturus Therapeutics Holdings Inc stock price yesterday was $18.13.
What is the PE ratio of Arcturus Therapeutics Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Arcturus Therapeutics Holdings Inc’s P/E ratio is -8.15.
What is the Price-to-Book ratio of Arcturus Therapeutics Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Arcturus Therapeutics Holdings Inc P/B ratio is 2.1302.
What is the 50-day moving average of Arcturus Therapeutics Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Arcturus Therapeutics Holdings Inc 50-day moving average is $15.40.
How many employess does Arcturus Therapeutics Holdings Inc has?
Arcturus Therapeutics Holdings Inc has 176 employees.